Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Matthew Norkunas | CHIEF FINANCIAL OFFICER | 2024-04-15 | 492 | $3.70 | $1.82kSell |
Matthew Norkunas | CHIEF FINANCIAL OFFICER | 2024-04-15 | 492 | $3.70 | $1.82kSell |
Yalonda Howze | CHIEF LEGAL OFFICER | 2024-04-15 | 3,930 | $3.70 | $14.54kSell |
Geoff McDonough | PRESIDENT AND CEO | 2024-04-15 | 1,548 | $3.70 | $5.73kSell |
Phillip Samayoa | CHIEF STRATEGY OFFICER | 2024-04-15 | 337 | $3.70 | $1.25kSell |
Antoinette Paone | CHIEF OPERATING OFFICER | 2024-04-15 | 468 | $3.70 | $1.73kSell |
Matthew Stanton | CHIEF SCIENTIFIC OFFICER | 2024-04-15 | 492 | $3.70 | $1.82kSell |
Douglas Kerr | CHIEF MEDICAL OFFICER | 2024-01-29 | 1,476 | $1.90 | $2.80kSell |
Tracy Zimmermann | CHIEF DEVELOPMENT OFFICER | 2024-01-29 | 1,476 | $1.90 | $2.80kSell |
Geoff McDonough | PRESIDENT AND CEO | 2024-01-15 | 8,121 | $1.91 | $15.51kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Atlas Venture Life Science Advisors LLC | 12.45% | 8,279,484 | $25.91M | Institution |
Atlas Venture Fund X LP | 12.45% | 8,278,876 | $25.91M | Insider |
Price T Rowe Associates Inc | 10.42% | 6,926,174 | $21.68M | Institution |
Fmr LLC | 8.05% | 5,352,399 | $16.75M | Institution |
William Seybold | 5.77% | 3,837,638 | $12.01M | Insider |
Zone Healthcare Holdings LLC | 5.77% | 3,837,638 | $12.01M | Insider |
Bellevue Group Ag | 5.44% | 3,617,080 | $11.32M | Institution |
Blackrock Inc | 4.77% | 3,168,415 | $9.92M | Institution |
Artal Group Sa | 4.23% | 2,814,191 | $8.81M | Institution |
Invus Public Equities LP | 4.23% | 2,814,191 | $8.81M | Insider |